Rebirth of the God-level Xueba

Northern United Pharmaceutical finally selected the factory site in Hebei. Tomato Novel Network☆w-w`w`. x-f`qxsw. com

Land in the capital is hard to find, even if it is outside the Sixth Ring Road where no one wants it, it is impossible to grant tens of thousands of acres of land in one go.

More than 30 years since the founding of the People's Republic of China, various units and departments have already occupied the large land. The remaining wilderness is either a reserve land left by the government, or there are various disputes. In addition, there are such existences as state-owned farms and logistics farms.

Although Hu Chi came out of Qiao's office and became the director of the Chemical Medicine Promotion Office, it was still a bit too challenging to ask for tens of thousands of acres of land in the suburbs of Beijing.

Furthermore, how can a unit like Northern United Pharmaceuticals, which is not loved by grandparents and loved by grandparents, get tens of thousands of acres of land in the suburbs of Beijing?

After two months of training in the barracks, the workers took off their green uniforms and put on gray overalls, and they no longer showed any resistance.

It is already thankful that the respected profession of state-owned enterprise workers can be preserved.

As for the cadres of the original company, they are even more lucky.

Can come back smoothly, the company cadres who have been disturbed and resettled are already a small number. Various companies including North China Pharmaceuticals are already overstaffed. If several companies are merged, the result will be even worse. Most of them can only wait for post. If you find something to do again, you will be lucky if you can go down to the county.

The 80s was originally an era of super editing.

Veteran cadres who are unwilling to retire, ordinary cadres who have been promoted normally and abnormally, and unlucky cadres who have returned from rehabilitation constitute an extremely large official era. It is quite common to have 11 deputy positions in one principal position.

The so-called problems left over from history are talking about such a situation. Rehabilitation is a big policy. The cadres who have been rehabilitated will naturally have to be arranged. The cadres who have been promoted normally have to make way for the rehabilitated cadres without reason. As for the old cadres not retiring, it is to help you and is the last light. Fever, before there is no policy of mandatory retirement, everyone is loyal to the country.

To some extent, people in the 1980s are actually used to this phenomenon.

Sometimes, more deputies also form short-term relative checks and balances.

That kind of situation where the top leader dominates is not easy to achieve in the middle and high-level in the 1980s. Among other things, the old revolutionaries of the Red Army period are still there. Even if young and middle-aged cadres are promoted, can they point to the old revolutionaries? nose curse? The reverse is more or less the case.

However,

Yang Rui didn't have such a concept, and he didn't want the newly born Northern United Pharmaceuticals to be so bloated.

Hu Chi trusts him extremely now, so he drives away the redundant cadres with kindness. Not only that, Northern United Pharmaceuticals is still short of staff, especially at the grassroots level, with a large number of vacancies. His posture stimulated the workers who had just finished their military training.

The only thing that makes it difficult for workers, or some workers to adapt, is their current job content.

"Why should I feed mice when others can install machines and build factories!" Fang Zhengye put on a white coat and rubber gloves, but he didn't feel the joy of wearing new clothes at all.

"It's not called a mouse, it's called a Chinese hamster." Duan Chang said casually after receiving temporary training.

"There are too many rats in China, is it worth letting us raise them? I've never seen such a manipulative one." Fang Zhengye's displeasure will not be reduced at all.

The worker next to him said: "They are used to make medicine."

"Isn't it disgusting to use rats as medicine? I would rather die than take it."

"The patient is not what you think. The Chinese hamster we raised here, and finally extracted cells, can treat Gaucher's disease. It is said that hundreds of thousands of people around the world suffer from this disease and die within a few years." Duan Chang's temper is not bad, and it was because of his good temper that he was sent to this workshop. Those section chiefs who need wheel wrenches at every turn have gone to the machinery and manufacturing workshops.

"Then if these hundreds of thousands of people have been cured, our workshop will be dismantled?" Another worker heard the chat and came over.

Duan Chang shook his head: "Goucher's disease can't be cured, and he can only take medicine to maintain it."

"Eat it all the time?"

"Well, it can't stop."

"That's not a medicine jar."

Fang Zhengye said: "The medicine jar is also better than the ashes jar."

"Now you understand what's going on, that's all, go to work after you understand everything. Let me tell you, our workshop is a core workshop, do you know that? There will be a lot to do in the future."

"At the core, it's not about raising mice." Fang Zhengye muttered, picking up the feeding dustpan in disgust, and began to feed one cage after another.

The drug for Gaucher's disease uses Chinese hamster ovary cells with recombinant DNA. After preliminary experiments, it will soon enter the stage of cell line culture, so-called cell engineering.

However, raising mice is indeed a big project. There are actually a lot of demands from so many biological laboratories and pharmaceutical institutions in China.

Later generations will have specialized factories to do this business. It is a technology-intensive and manpower-intensive industry. Yang Rui opened a project for Northern United Pharmaceuticals, which can be regarded as reducing the cost of biological researchers across the country.

In addition to the "core workshop", a large number of ordinary workshops have entered a state of full-scale construction. ,

In order to feed the large number of workers in the northern pharmaceutical industry, they basically inherited the previous pharmaceutical production. Although it is difficult to obtain high profits in the manufacture of a large number of ordinary drugs, it is not bad to ensure that the balance of payments is guaranteed.

In addition, the license to produce medicines is also considered a scarce resource.

The pharmaceutical companies in the 1980s were all state-owned enterprises, and it was not difficult for everyone to apply for one or two licenses, so the value of the licenses could not be reflected. It's like a car owner in a small city who can't appreciate the rarity of license plates in Beijing and Shanghai.

This is the last state-owned enterprise aftertaste. In a few years, as the demand for licenses from private enterprises increases, let alone a drug license for a warehouse, a license for ammonia plus Huangmin will reach a seven-figure asking price.

As an intangible asset, this is the advantage of Northern United Pharmaceuticals. Its scale is large, so there are many production lines that can be opened, and there are many drug licenses that can be saved. They will not be needed in the future, and they can be sold to replace the equipment in the factory.

As for now, Northern United Pharmaceuticals continues to use the old equipment from the original factory, which can be regarded as a profit point in disguise. Even if the production line cannot make money, the retained license plate, or even the newly applied license plate, can always be exchanged for some money.

Chinese cadres like this traditional business model very much. They have been doing this for decades, and they don’t think that making cold medicine is low-end. It’s better than making Chinese medicine. At least there are still hanging on the wall of our workshop A chemical formula.

On the other hand, Zeneca doesn't care about the first batch of workshops built after spending money.

They paid more than 30 million US dollars to get 49% of the shares, and they didn't make concessions for such a simple product.

Zeneca is completely optimistic about the research and development of orphan drugs for Gaucher disease. However, even with the standard of deferiprone, Zeneca is betting that Yang Rui will pass the second clinical phase.

Considering that deferiprone has completed all the milestones, so that the price is extremely high, Zeneca still gives a considerable premium to the orphan drug of Gaucher disease.

Regarding this, Yang Rui can only say: Those who believe in me will make money.

Recombinant dna technology, in 1986, is still quite cutting-edge and high-end, and there are basically no large-scale pharmaceuticals, and many laboratories are still exploring.

However, for Yang Rui, recombining DNA or something is really too simple, okay?

After only one night of effort, Yang Rui wrote down what to order.

If it weren't for avoiding shocking the world, he would have to pretend to be a guide and enlightenment. This job can be directly subcontracted by the scientific research dog.

...